Efimosfermin Alfa
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Efimosfermin Alfa, covering 2025-12-24 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH [Phase 3]